Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphopyruvate hydratase activity	ENO1 ENO2 ENO3	1.31e-06	4	139	3	GO:0004634
GeneOntologyCellularComponent	phosphopyruvate hydratase complex	ENO1 ENO2 ENO3	1.17e-06	4	140	3	GO:0000015
Domain	Enolase_N	ENO1 ENO2 ENO3	3.95e-07	3	138	3	PF03952
Domain	Enolase	ENO1 ENO2 ENO3	3.95e-07	3	138	3	IPR000941
Domain	Enolase_C	ENO1 ENO2 ENO3	3.95e-07	3	138	3	IPR020810
Domain	Enolase_N	ENO1 ENO2 ENO3	3.95e-07	3	138	3	IPR020811
Domain	Enolase_CS	ENO1 ENO2 ENO3	3.95e-07	3	138	3	IPR020809
Domain	Enolase_C	ENO1 ENO2 ENO3	3.95e-07	3	138	3	PF00113
Domain	Enolase_N	ENO1 ENO2 ENO3	3.95e-07	3	138	3	SM01193
Domain	Enolase_C	ENO1 ENO2 ENO3	3.95e-07	3	138	3	SM01192
Domain	ENOLASE	ENO1 ENO2 ENO3	3.95e-07	3	138	3	PS00164
Domain	-	ENO1 ENO2 ENO3	1.57e-06	4	138	3	3.30.390.10
Domain	-	ENO1 ENO2 ENO3	1.57e-06	4	138	3	3.20.20.120
Domain	Enolase_C-like	ENO1 ENO2 ENO3	1.57e-06	4	138	3	IPR029065
Domain	Enolase_N-like	ENO1 ENO2 ENO3	1.57e-06	4	138	3	IPR029017
Domain	MamL-1	MAML1 MAML3	1.62e-04	3	138	2	SM01275
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML3	1.62e-04	3	138	2	IPR019082
Domain	MamL-1	MAML1 MAML3	1.62e-04	3	138	2	PF09596
Domain	GATase	CAD GMPS	5.34e-04	5	138	2	PF00117
Domain	GATASE_TYPE_1	CAD GMPS	7.97e-04	6	138	2	PS51273
Domain	DUF3398	DOCK11 DOCK9	7.97e-04	6	138	2	PF11878
Domain	GATASE	CAD GMPS	7.97e-04	6	138	2	IPR017926
Domain	EF-hand_dom_typ1	DRP2 UTRN	7.97e-04	6	138	2	IPR015153
Domain	EF-hand_dom_typ2	DRP2 UTRN	7.97e-04	6	138	2	IPR015154
Domain	DOCK_C/D_N	DOCK11 DOCK9	7.97e-04	6	138	2	IPR021816
Domain	EF-hand_2	DRP2 UTRN	7.97e-04	6	138	2	PF09068
Domain	EF-hand_3	DRP2 UTRN	7.97e-04	6	138	2	PF09069
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	UNC13B MAN2A2 CDK12 DOCK9 KHNYN MAML1 EXTL3 MED13L BCL9 WNK1 BIRC6 SLC2A1 CABLES1 PIKFYVE CPSF1 UNKL TNKS1BP1 DNMBP AHNAK2 BAHCC1	3.38e-08	1105	144	20	35748872
Pubmed	A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA.	ENO1 ENO2 ENO3	2.77e-07	4	144	3	25918939
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	DSG2 CDK12 CAMK4 WNK1 KHSRP GMPS PDIA6 RBM12 AFG3L2 GNL2 TNKS1BP1 KIF5B SNX9 ENO1 UTRN SOD1 AHNAK2	3.63e-07	934	144	17	33916271
Pubmed	Experimental models of amyotrophic lateral sclerosis.	VPS54 IGHMBP2 SOD1	6.91e-07	5	144	3	10527800
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CAD INPP5D MAML1 CHD9 RAD54L2 MED13L BCL9 DDX55 KHSRP GMPS RBM12 CELF1 ATXN2 ZBTB40 SMARCD2 KIF5B SNX9 CAPRIN1	7.79e-07	1103	144	18	34189442
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	DPYD DOCK11 DOCK9 CHD9 CABLES1 PI3 FBXO22 HOXD11 IGHMBP2 AFG3L2 GNL2 CPSF1	1.20e-06	497	144	12	36774506
Pubmed	Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells.	ENO1 ENO2 ENO3	1.38e-06	6	144	3	19433310
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	DNAJB12 TRIM71 GMPS TAF6L FBXO3 ATXN2 GNL2 TNKS1BP1 CAPRIN1 TGS1	3.09e-06	364	144	10	24778252
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DNAJB12 CAD FLYWCH1 DSG2 CDK12 TOPBP1 MAML1 DDX55 N4BP3 SLC2A1 TAF6L COL18A1 PDIA6 ZKSCAN1 ATXN2 IGHMBP2 AFG3L2 GNL2 DNMBP UTRN	3.91e-06	1497	144	20	31527615
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CDK12 DOCK9 MED13L WNK1 BIRC6 RBM12 ZBTB40 TNKS1BP1	4.79e-06	225	144	8	12168954
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CAD TOPBP1 MAML1 RAD54L2 WNK1 PIKFYVE AFG3L2 TNKS1BP1 BSN CFAP44 DNMBP SNX9	6.68e-06	588	144	12	38580884
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MAN2A2 DOCK9 WNK1 BIRC6 AFG3L2 ZBTB40 CDK5RAP2 ENO1 UTRN ENO3 TGS1	7.71e-06	497	144	11	23414517
Pubmed	Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data.	CAD GMPS ALDH5A1	8.17e-06	10	144	3	20659789
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CAD VPS54 MED13L DDX55 WNK1 BIRC6 USP19 KHSRP TWIST1 GMPS TAF6L ZBTB40 CPSF1 UNKL STH ENO3 CAPRIN1 FBXW7	1.01e-05	1327	144	18	32694731
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	COL4A1 DNAJB12 MAN2A2 DSG2 EXTL3 SSR2 DDX55 USP19 KHSRP COL18A1 PDIA6 FBXO22 CPSF1 TNKS1BP1 TIMELESS KIF5B RAB21	1.06e-05	1201	144	17	35696571
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	CAD SLC2A1 KHSRP PDIA6 FBXO22 ENO1 CAPRIN1	1.15e-05	182	144	7	31067453
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	UNC13B MAN2A2 DSG2 CDK12 EML4 TRIM71 DDX55 KHSRP COL18A1 ATXN2 GNL2 CPSF1 SMARCD2 KIF5B RAB21 ENO1 CAPRIN1 SOD1	1.57e-05	1371	144	18	36244648
Pubmed	Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.	ENO1 ENO2	1.70e-05	2	144	2	30779465
Pubmed	MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.	MAML1 TWIST1	1.70e-05	2	144	2	29333702
Pubmed	Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development.	ENO1 ENO3	1.70e-05	2	144	2	2090519
Pubmed	FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.	ENO1 FBXW7	1.70e-05	2	144	2	26097998
Pubmed	HUPO BPP pilot study: a proteomics analysis of the mouse brain of different developmental stages.	ENO1 ENO2	1.70e-05	2	144	2	17922513
Pubmed	Association analysis of four candidate genetic variants with sporadic amyotrophic lateral sclerosis in a Chinese population.	TIAM1 SOD1	1.70e-05	2	144	2	24493373
Pubmed	Nucleotide sequences of cDNAs alpha and gamma enolase mRNAs from mouse brain.	ENO1 ENO2	1.70e-05	2	144	2	2362815
Pubmed	Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases.	ENO1 ENO2	1.70e-05	2	144	2	22551201
Pubmed	Complete structure of the human gene encoding neuron-specific enolase.	ENO1 ENO2	1.70e-05	2	144	2	2045099
Pubmed	Lecithinized superoxide dismutase retards wobbler mouse motoneuron disease.	VPS54 SOD1	1.70e-05	2	144	2	7496172
Pubmed	Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer's disease.	ZBTB20 TRPV4	1.70e-05	2	144	2	23889563
Pubmed	MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.	MAML1 TWIST1	1.70e-05	2	144	2	32180088
Pubmed	Isolation of murine neuron-specific and non-neuronal enolase cDNA clones.	ENO1 ENO2	1.70e-05	2	144	2	3801001
Pubmed	Elucidated tumorigenic role of MAML1 and TWIST1 in gastric cancer is associated with Helicobacter pylori infection.	MAML1 TWIST1	1.70e-05	2	144	2	34818576
Pubmed	Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins.	ENO1 ENO3	1.70e-05	2	144	2	9169614
Pubmed	Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.	MAML1 TWIST1	1.70e-05	2	144	2	22006371
Pubmed	Fibre-type distribution and subcellular localisation of alpha and beta enolase in mouse striated muscle.	ENO1 ENO3	1.70e-05	2	144	2	11229603
Pubmed	Passenger deletions generate therapeutic vulnerabilities in cancer.	ENO1 ENO2	1.70e-05	2	144	2	22895339
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	FLYWCH1 TOPBP1 RAD54L2 MED13L SLC2A1 KHSRP TAF6L FBXO22 AFG3L2 SMARCD2	2.07e-05	453	144	10	29656893
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	DNAJB12 CAD EML4 DDX55 WNK1 BIRC6 KHSRP GMPS PDIA6 FBXO22 FBXO3 AFG3L2 GNL2 TNKS1BP1 KIF5B ENO1 CAPRIN1 AHNAK2	2.38e-05	1415	144	18	28515276
Pubmed	Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.	LACRT DMBT1 ENO1 ENO2 ENO3 TGS1	3.83e-05	149	144	6	22664934
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	CAD BCL9 KHSRP ATXN2 CPSF1 LACRT ENO1	3.89e-05	220	144	7	24550385
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	CAD KHSRP GMPS PDIA6 FBXO3 ENO1 ALDH5A1 CAPRIN1 SOD1 BAHCC1	4.37e-05	495	144	10	28581483
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FLYWCH1 DOCK9 WNK1 SLC2A1 COL18A1 CELF1 ZBTB40 ZBTB10 CDK5RAP2 TIMELESS CPLANE1 UTRN NLRP4 SOD1 TGS1	4.66e-05	1084	144	15	11544199
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	DNAJB12 CAD ARMCX4 DDX55 BIRC6 SLC2A1 USP19 PIKFYVE ATXN2 AFG3L2 COA1 GNL2 CPSF1 HINT2 CDK5RAP2 ALDH5A1 CAPRIN1 AHNAK2	4.91e-05	1496	144	18	32877691
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CAD CDK12 TOPBP1 WNK1 CABLES1 KHSRP PDIA6 SMARCD2 TNKS1BP1 TIMELESS	5.00e-05	503	144	10	16964243
Pubmed	Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling.	MAML1 MAML3	5.09e-05	3	144	2	12386158
Pubmed	Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI).	COL4A1 TWIST1	5.09e-05	3	144	2	26973246
Pubmed	Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein.	ENO2 ENO3	5.09e-05	3	144	2	22087329
Pubmed	ALS-associated genes in SCA2 mouse spinal cord transcriptomes.	ATXN2 SOD1	5.09e-05	3	144	2	32307524
Pubmed	Disparate Regulatory Mechanisms Control Fat3 and P75NTR Protein Transport through a Conserved Kif5-Interaction Domain.	FAT3 KIF5B	5.09e-05	3	144	2	27788242
Pubmed	FBXO3 stabilizes USP4 and Twist1 to promote PI3K-mediated breast cancer metastasis.	TWIST1 FBXO3	5.09e-05	3	144	2	38134227
Pubmed	The SWI/SNF protein BAF60b is ubiquitinated through a signalling process involving Rac GTPase and the RING finger protein Unkempt.	SMARCD2 UNKL	5.09e-05	3	144	2	20148946
Pubmed	Roles of the DOCK-D family proteins in a mouse model of neuroinflammation.	DOCK11 DOCK9	5.09e-05	3	144	2	32241915
Pubmed	WNK kinases influence TRPV4 channel function and localization.	WNK1 TRPV4	5.09e-05	3	144	2	16403833
Pubmed	Inhibition of KHSRP sensitizes colorectal cancer to 5-fluoruracil through miR-501-5p-mediated ERRFI1 mRNA degradation.	KHSRP ERRFI1	5.09e-05	3	144	2	31313286
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	DOCK9 WNK1 SLC2A1 ATXN2 DNMBP SNX9 UTRN	5.15e-05	230	144	7	35449600
Pubmed	Hox5 interacts with Plzf to restrict Shh expression in the developing forelimb.	TWIST1 HOXC5 HOXD11	7.53e-05	20	144	3	24218595
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FLYWCH1 CDK12 TOPBP1 MAML1 DDX55 RBM12 CDK5RAP2 TNKS1BP1 BSN DNMBP	7.59e-05	529	144	10	14621295
Pubmed	Isolation of novel tissue-specific genes from cDNA libraries representing the individual tissue constituents of the gastrulating mouse embryo.	MAML1 TRIM71 CLIC6 PDIA6 CELF1 KIF5B CFAP44 ENO1 CAPRIN1	8.41e-05	432	144	9	7671812
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CAD BIRC6 KHSRP GMPS GNL2 CPSF1 TNKS1BP1 KIF5B SNX9 UTRN CAPRIN1	9.23e-05	653	144	11	22586326
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CAD DSG2 KHSRP TAF6L PDIA6 AFG3L2 GNL2 CPSF1 HINT2 KIF5B RAB21 SNX9 ENO1 UTRN	9.58e-05	1024	144	14	24711643
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	DNAJB12 CAD DSG2 DDX55 WNK1 BIRC6 SLC2A1 GMPS COL18A1 PDIA6 FBXO22 FBXO3 AFG3L2 TNKS1BP1 RAB21 CAPRIN1	9.95e-05	1297	144	16	33545068
Pubmed	Protein kinase WNK1 promotes cell surface expression of glucose transporter GLUT1 by regulating a Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4)-Rab8A complex.	WNK1 SLC2A1	1.02e-04	4	144	2	20937822
Pubmed	CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer.	ENO1 FBXW7	1.02e-04	4	144	2	34335983
Pubmed	Epithelial mesenchymal transition regulator TWIST1 transcription factor stimulates glucose uptake through upregulation of GLUT1, GLUT3, and GLUT12 in vitro.	SLC2A1 TWIST1	1.02e-04	4	144	2	34791627
Pubmed	A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS).	COL6A5 COL18A1	1.02e-04	4	144	2	19961619
Pubmed	Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.	PDIA6 COA1	1.02e-04	4	144	2	26655997
Pubmed	Modulation of embryonic and muscle-specific enolase gene products in the developing mouse hindlimb.	ENO1 ENO3	1.02e-04	4	144	2	1280607
Pubmed	A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR.	ZKSCAN1 FBXW7	1.02e-04	4	144	2	36691031
Pubmed	WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.	WNK1 SLC2A1	1.02e-04	4	144	2	31816312
Pubmed	Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis.	KHSRP PDIA6 ENO1 ENO2 ENO3	1.26e-04	116	144	5	37117180
Pubmed	14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.	KHSRP GMPS PDIA6 TIAM1 KIF5B FBXW7	1.31e-04	186	144	6	14744259
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	PAPPA2 DOCK11 DOCK9 WNK1 BIRC6 USP19 CDK5RAP2 UTRN	1.43e-04	363	144	8	14691545
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	CAD MED13L KHSRP DMBT1 SNX9 ENO1 CAPRIN1	1.46e-04	272	144	7	31010829
Pubmed	Identification of host proteins required for HIV infection through a functional genomic screen.	BCL9 DDX55 WNK1 TMEM132C PDIA6 RPTN IGHMBP2	1.46e-04	272	144	7	18187620
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CAD EML4 BIRC6 SLC2A1 KHSRP GMPS PDIA6 FBXO22 AFG3L2 ZBTB10 CPSF1 KIF5B ENO1 UTRN CAPRIN1 AHNAK2	1.61e-04	1353	144	16	29467282
Pubmed	Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.	MAML1 FBXW7	1.69e-04	5	144	2	26108681
Pubmed	The TNF superfamily.	TNFRSF14 LTB	1.69e-04	5	144	2	12787557
Pubmed	Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission.	UNC13B ABCA4	1.69e-04	5	144	2	33139401
Pubmed	LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.	TNFRSF14 LTB	1.69e-04	5	144	2	17982081
Pubmed	Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy.	DRP2 UTRN	1.69e-04	5	144	2	11430802
Pubmed	Mammalian carboxylesterase 3: comparative genomics and proteomics.	CES1 CES4A	1.69e-04	5	144	2	20422440
Pubmed	The intracellular domain of Jagged-1 interacts with Notch1 intracellular domain and promotes its degradation through Fbw7 E3 ligase.	MAML1 FBXW7	1.69e-04	5	144	2	21820430
Pubmed	Zizimin2: a novel, DOCK180-related Cdc42 guanine nucleotide exchange factor expressed predominantly in lymphocytes.	DOCK11 DOCK9	1.69e-04	5	144	2	15710388
Pubmed	Tbx1 regulates brain vascularization.	SLC2A1 TBX1	1.69e-04	5	144	2	23945394
Pubmed	Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study.	TIAM1 SOD1	1.69e-04	5	144	2	20801718
Pubmed	Animal models for motor neuron disease.	VPS54 SOD1	1.69e-04	5	144	2	10551448
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CAD ROGDI CDK12 CHD9 TRIM71 DDX55 ZC3H6 SLC2A1 KHSRP PDIA6 FBXO3 GNL2 CPSF1 TNKS1BP1	1.70e-04	1082	144	14	38697112
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	TRIML2 DOCK9 GNL2 CPSF1 UTRN	1.79e-04	125	144	5	29467281
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	ROGDI OXR1 DSG2 VPS54 PIKFYVE RAB21 CAPRIN1	1.95e-04	285	144	7	34369648
Pubmed	ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease.	OXR1 WNK1 GMPS KIF5B BSN CAPRIN1	2.04e-04	202	144	6	33601422
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	DOCK11 EML4 DDX55 KHSRP CELF1 ATXN2 SMARCD2 DNMBP SNX9 CAPRIN1 AHNAK2	2.26e-04	724	144	11	36232890
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	CHD9 SLC2A1 TAF6L AFG3L2 CDK5RAP2 BSN	2.39e-04	208	144	6	33230847
Pubmed	Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse.	DRP2 UTRN	2.53e-04	6	144	2	9245586
Pubmed	Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamics.	MAML1 FBXW7	2.53e-04	6	144	2	35821235
Pubmed	A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.	TNFRSF14 LTB	2.53e-04	6	144	2	10318773
Pubmed	Activation of the gene encoding the glycolytic enzyme beta-enolase during early myogenesis precedes an increased expression during fetal muscle development.	ENO1 ENO3	2.53e-04	6	144	2	1525038
Pubmed	The RhoGEF DOCK10 is essential for dendritic spine morphogenesis.	DOCK11 DOCK9	2.53e-04	6	144	2	25851601
Pubmed	Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins.	CES1 CES4A	2.53e-04	6	144	2	20931200
Pubmed	Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth.	DRP2 UTRN	2.53e-04	6	144	2	22764250
Pubmed	The X-chromosome-linked intellectual disability protein PQBP1 is a component of neuronal RNA granules and regulates the appearance of stress granules.	KHSRP CAPRIN1	2.53e-04	6	144	2	21933836
Pubmed	A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection.	TNFRSF14 LTB	2.53e-04	6	144	2	15905567
Interaction	AKR1B15 interactions	ENO1 ENO2 SOD1 FBXW7	2.12e-06	14	140	4	int:AKR1B15
GeneFamily	Carboxylesterases	CES1 CES4A	3.00e-04	5	100	2	461
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	PAPPA2 DPYD ZBTB20 TMED6 FAT3 FRMPD2 CHD9 CLIC6 BIRC6 GMPS TMEM132C HOXC5 ZKSCAN1 ATXN2 SLC25A44 C1R CPLANE1 UTRN AHNAK2	9.06e-07	797	137	19	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000	PAPPA2 DPYD ZBTB20 TMED6 FAT3 FRMPD2 CLIC6 HOXC5 C1R AHNAK2	2.52e-06	230	137	10	gudmap_developingGonad_P2_epididymis_1000_k2
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	PAPPA2 ZBTB20 TMED6 DOCK11 FAT3 FRMPD2 CHD9 BIRC6 GMPS TMEM132C HOXC5 ATXN2 SLC25A44 C1R CPLANE1 ENO2 UTRN AHNAK2	3.98e-06	799	137	18	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	CDK12 FAT3 BCL9 ZC3H6 PCDH17 ZKSCAN1 CPLANE1 CAPRIN1	5.67e-06	149	137	8	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	CDK12 FAT3 EXTL3 BCL9 BIRC6 ZC3H6 PCDH17 CELF1 ZKSCAN1 CPLANE1 CAPRIN1	5.92e-06	312	137	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	CDK12 FAT3 TRIM71 EXTL3 BCL9 WNK1 BIRC6 PCDH17 ZKSCAN1 CPLANE1 DNMBP CAPRIN1	7.72e-06	385	137	12	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	DPYD ZBTB20 DOCK11 CDK12 FAT3 FRMPD2 CHD9 BIRC6 GMPS TMEM132C HOXC5 ATXN2 SLC25A44 CPLANE1 UTRN AHNAK2	5.16e-05	790	137	16	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	DRP2 CDK12 CAMK4 FAT3 EXTL3 BCL9 BIRC6 ZC3H6 PCDH17 TWIST1 TMEM132C CELF1 ZKSCAN1 TIAM1 CPLANE1 CAPRIN1	6.53e-05	806	137	16	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	ZBTB20 MAN2A2 DSG2 DOCK11 CAMK4 TRIM71 PPP1R15A BCL9 WNK1 TWIST1 TMEM132C TAF6L TIAM1 GNL2 CDK5RAP2 GPC5 ENO1 MAML3	6.82e-05	989	137	18	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	CDK12 FAT3 BCL9 ZC3H6 PCDH17 TWIST1 TMEM132C ZKSCAN1 TIAM1 CPLANE1 CAPRIN1	6.84e-05	407	137	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4	DSG2 DOCK11 CAMK4 TRIM71	1.14e-04	39	137	4	Facebase_RNAseq_e10.5_Maxillary Arch_500_K4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000	PAPPA2 ZBTB20 TMED6 FAT3 FRMPD2 C1R ENO2 AHNAK2	1.42e-04	234	137	8	gudmap_developingGonad_e18.5_epididymis_1000_k5
ToppCell	droplet-Bladder-BLADDER-1m-Hematologic-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPSTI1 DOCK11 CAMK4 INPP5D CDK5RAP2 TIMELESS GIMAP6 TGS1	1.64e-07	185	144	8	969248b63d4ce335f223528de756bcddffadbd77
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CCDC30 CES1 FRMPD2 CES4A CPLANE1 CFAP44 ALOX15 AHNAK2	2.27e-07	193	144	8	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSG2 CES1 PI3 RPTN CPLANE1 CFAP44 ALOX15 AHNAK2	2.65e-07	197	144	8	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZBTB20 SSR2 SLC2A1 TWIST1 ERRFI1 C1R ENO1 ENO2	2.86e-07	199	144	8	9838fed26d8572ac29e7b5fd7220180f734d750a
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DPYD ZBTB20 VPS54 MED13L BIRC6 UTRN MAML3 FBXW7	2.86e-07	199	144	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	COL4A1 MAML1 MED13L WNK1 PCDH17 KHSRP ZBTB10 UTRN	2.86e-07	199	144	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Severe-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	COL4A1 EPSTI1 PPP1R15A ZBTB10 LTB RAB21 SNX9	1.44e-06	171	144	7	61205a4986c2d0a89aea96ed8dec9e952eeb6ff1
ToppCell	10x5'v1-week_17-19-Lymphocytic_T-T_NK-CD8_T_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CAMK4 COL18A1 TRBV5-1 LTB OLFM2 BSN GIMAP6	2.18e-06	182	144	7	98c26ad34e01c4b8997d26d5d28a9935491295fa
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL4A1 INPP5D ARMCX4 N4BP3 PCDH17 UNC45B GIMAP6	2.18e-06	182	144	7	7af3b2029b7f55b923d5a4b764d4292f4ea48599
ToppCell	E18.5-samps-Endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL4A1 INPP5D ARMCX4 N4BP3 PCDH17 UNC45B GIMAP6	2.18e-06	182	144	7	e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPSTI1 EML4 CHD9 PPP1R15A BIRC6 SNX9 UTRN	2.34e-06	184	144	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DOCK9 MAML1 CHD9 ARMCX4 PPP1R15A TIAM1 RAB21	2.60e-06	187	144	7	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DOCK9 MAML1 CHD9 ARMCX4 PPP1R15A TIAM1 RAB21	2.60e-06	187	144	7	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 ARMCX4 PCDH17 TWIST1 SLC15A1 UNC45B GIMAP6	3.10e-06	192	144	7	5890076929598e88fe9d59a4e4e858b446746ce9
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DPYD ZBTB20 MED13L BIRC6 SNX9 UTRN MAML3	3.21e-06	193	144	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 ARMCX4 PCDH17 TWIST1 SLC15A1 UNC45B GIMAP6	3.21e-06	193	144	7	4a8c97ff2dffc5c06351d1cb107e21e58250aa55
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 ARMCX4 PCDH17 TWIST1 SLC15A1 UNC45B GIMAP6	3.21e-06	193	144	7	d5f6d6e2c36d4e80af4d39cdfc0b18df295a587b
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CES1 CLIC6 ERICH5 TWIST1 HINT2 ALOX15 SOD1	3.55e-06	196	144	7	d9426eba69047166ffa8179f1654e011c1020328
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CES1 CLIC6 ERICH5 TWIST1 HINT2 ALOX15 SOD1	3.55e-06	196	144	7	7e19919eafd6ddf547dd4e8aa532a050e182c5cc
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZBTB20 SLC2A1 TWIST1 ERRFI1 C1R ENO1 ENO2	3.92e-06	199	144	7	cfe6f881a86607544e1413ef38e4b6797ef1a61c
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLB1 ABCA4 CLIC6 CSRNP3 TBX1 AHNAK2	5.88e-06	138	144	6	611fe0fb284e12678f9c47a0bdbfc367a93c52b3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLB1 CAMK4 BCL9 TIAM1 LTB ALDH5A1	1.32e-05	159	144	6	b9d34b9ed8db798f5ea93c44b469cae499403cb8
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Thalamus / BrainAtlas - Mouse McCarroll V32	EXTL3 CELF1 TIAM1 AHNAK2 FBXW7	1.85e-05	100	144	5	20675fc2ffc5ab63047d38da083b50d470f3db19
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6\|Thalamus / BrainAtlas - Mouse McCarroll V32	EXTL3 CELF1 TIAM1 AHNAK2 FBXW7	1.85e-05	100	144	5	1de3895e16f14ff32b901b18ce14d965afaa7e76
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora\|Thalamus / BrainAtlas - Mouse McCarroll V32	EXTL3 CELF1 TIAM1 AHNAK2 FBXW7	1.85e-05	100	144	5	ff1bdb511700a041a90034d1d30dfc25f51d6c82
ToppCell	facs\|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 BIRC6 RAB21 SNX9 ENO1 SOD1	2.06e-05	172	144	6	a2d0a64ebf09d219a07d6bbad1056bad6d46b9be
ToppCell	CV-Healthy-4\|Healthy / Virus stimulation, Condition and Cluster	CAMK4 N4BP3 SLC2A1 MMEL1 ENO1 ENO2	2.20e-05	174	144	6	26544cc5f51cb4dc1251e62d9f80b6c956194d38
ToppCell	facs\|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BIRC6 DNAJB13 RAB21 SNX9 ENO1 SOD1	2.27e-05	175	144	6	53e96956019f984decc1c81376ebc88fbf3c4d40
ToppCell	facs-Skin-Anagen-24m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAMK4 COL18A1 HOXC5 ZNF76 TRPV4 TBX1	2.27e-05	175	144	6	5552ff1e13f931c8cd7780726c90b5609497a648
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 OXR1 DOCK11 FAT3 UTRN MAML3	2.42e-05	177	144	6	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPSTI1 EML4 CAMK4 WNK1 TIAM1 LTB	2.75e-05	181	144	6	a6c8b33a392de3df2f179317e329e45d3d8c6f52
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL4A1 DOCK9 N4BP3 PCDH17 UNC45B TIMELESS	2.75e-05	181	144	6	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ZBTB20 EPSTI1 CDK12 CHD9 PPP1R15A UTRN	2.92e-05	183	144	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Trachea-nan-3m-Endothelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.01e-05	184	144	6	fa5c3020e75fdde1363393dea97ebd99f1eae9ff
ToppCell	droplet-Trachea-3m-Endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.01e-05	184	144	6	ad520ab6bb776b5303df505b7e1afb22484f18a7
ToppCell	droplet-Trachea-nan-3m-Endothelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.01e-05	184	144	6	1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645
ToppCell	droplet-Trachea-nan-3m-Endothelial-endothelial_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.01e-05	184	144	6	76caad53d55fff5acca27bf190a6de7b27437d9f
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.01e-05	184	144	6	1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.01e-05	184	144	6	2467207aaea307873ab286f89cfc7668a227a694
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	DSG2 DOCK9 PCDHAC1 N4BP3 SNX9 AHNAK2	3.01e-05	184	144	6	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	E12.5-Endothelial-capillary_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A1 ABCA4 N4BP3 PCDH17 COL18A1 GIMAP6	3.10e-05	185	144	6	e005d3c01a908157f780bbc1d53dd2ed814a39d2
ToppCell	E12.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A1 ABCA4 N4BP3 PCDH17 COL18A1 GIMAP6	3.10e-05	185	144	6	0bccc424d0466f7f82baa00127c733640a2d50fb
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	INPP5D DOCK9 N4BP3 LTB GIMAP6 TBX1	3.20e-05	186	144	6	86b218a400f9c64f92b050f00b49f09647b17437
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	INPP5D DOCK9 N4BP3 LTB GIMAP6 TBX1	3.20e-05	186	144	6	f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	INPP5D DOCK9 N4BP3 SLC2A1 PCDH17 GIMAP6	3.30e-05	187	144	6	106f50ad85a92403037214f0e94702230284837f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CAMK4 SDR42E2 ZBTB10 LTB SNX9 SOD1	3.40e-05	188	144	6	939790f133eac9c12d08db6ddb5f08f5107844e3
ToppCell	PND07-28-samps-Endothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.50e-05	189	144	6	eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 DOCK9 PCDH17 UNC45B UTRN GIMAP6	3.50e-05	189	144	6	393ec5954a12d6cf67bb435dcc34ff0b14c81e9f
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EPSTI1 CAMK4 TIAM1 OLFM2 SNX9 SOD1	3.50e-05	189	144	6	9f6f6fe6e47f5c5fd48aab47a775f7bdd16de19c
ToppCell	facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 DOCK9 PCDH17 UNC45B UTRN GIMAP6	3.50e-05	189	144	6	bec57459ad4bab15b2532b57722549fec2e771fb
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.50e-05	189	144	6	28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL4A1 DOCK9 PCDH17 UNC45B TIMELESS GIMAP6	3.50e-05	189	144	6	d4a25d59d88325d3b20f4287e9b1160c82961a96
ToppCell	Severe-B_activate-7\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	EPSTI1 PPP1R15A ZBTB10 LTB RAB21 SNX9	3.60e-05	190	144	6	67e6c8a5a8724bdf2861fd76a711319dfc71d47a
ToppCell	droplet-Fat-BAT+GAT+MAT\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB20 FLYWCH1 N4BP3 PCDH17 LTB GIMAP6	3.71e-05	191	144	6	4a201939e418f7268be09d59e08fc99f238a4136
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 DOCK9 N4BP3 UNC45B UTRN GIMAP6	3.71e-05	191	144	6	a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1
ToppCell	droplet-Fat-BAT+GAT+MAT-30m\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB20 FLYWCH1 N4BP3 PCDH17 LTB GIMAP6	3.71e-05	191	144	6	fa4e9ffdcde10b832d8ad2b6b4a704ac8b681e2e
ToppCell	(4)_Endothelial_cells-(41)_EC-arteriolar\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL4A1 N4BP3 PCDH17 COL18A1 UNC45B GIMAP6	3.71e-05	191	144	6	718c83046668a7c33bd8319b45c56f8edb34cfe7
ToppCell	facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 DOCK9 N4BP3 UNC45B UTRN GIMAP6	3.71e-05	191	144	6	827be47d3574c6c5b021c6f1c1670834344f10cb
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CAMK4 PPP1R15A SDR42E2 TRBV5-1 LTB SOD1	3.71e-05	191	144	6	dabb2d0210e39455db99db155cb36a3b6af43f37
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	EML4 VPS54 MED13L WNK1 ATXN2 UTRN	3.82e-05	192	144	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZBTB20 SLC2A1 ERRFI1 C1R ENO1 ENO2	3.82e-05	192	144	6	2dee0402e97e48157e0bc01bcc8034f1645dfb7b
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 CAMK4 N4BP3 PCDH17 UNC45B GIMAP6	3.82e-05	192	144	6	e4dd24aefdf13cd4206714f02fde2288f3173ffc
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B COL4A1 SLC2A1 UNC45B UTRN GIMAP6	3.82e-05	192	144	6	9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B COL4A1 SLC2A1 UNC45B UTRN GIMAP6	3.82e-05	192	144	6	a116db7dec495e5a0ba9c7537057cd1e567d7885
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B DOCK9 CABLES1 ERRFI1 GPC5 DMBT1	3.82e-05	192	144	6	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B COL4A1 SLC2A1 UNC45B UTRN GIMAP6	3.82e-05	192	144	6	66defad13bd8e79319741e43ddb056841710b1d7
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 N4BP3 SLC2A1 UTRN GIMAP6 TBX1	3.93e-05	193	144	6	e4b440d50ae7391b26924778be6d9d53e0692449
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 N4BP3 SLC2A1 UTRN GIMAP6 TBX1	3.93e-05	193	144	6	e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9
ToppCell	E15.5-Endothelial-capillary_endothelial_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A1 CAMK4 N4BP3 PCDH17 UNC45B GIMAP6	3.93e-05	193	144	6	3b3ffba483d114e9036a6fc64895fc37fc19d3e5
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 N4BP3 SLC2A1 UTRN GIMAP6 TBX1	3.93e-05	193	144	6	1772f2ac217727de63c4a9303881b3a19a6bb0f0
ToppCell	E15.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A1 CAMK4 N4BP3 PCDH17 UNC45B GIMAP6	3.93e-05	193	144	6	1719a741f8458f658e2965853020f485c22d6106
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	EML4 VPS54 MED13L WNK1 ATXN2 UTRN	3.93e-05	193	144	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FRMPD2 CLIC6 ERICH5 DNAJB13 CFAP44 ALOX15	4.05e-05	194	144	6	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	390C-Lymphocytic-CD4_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EML4 CAMK4 PPP1R15A LTB SNX9 SOD1	4.05e-05	194	144	6	76c4c3ba5f1bcc39d397c90db3513f5bea632b1b
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CCDC30 CES1 FRMPD2 DNAJB13 CES4A CFAP44	4.16e-05	195	144	6	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CCDC30 CES1 FRMPD2 DNAJB13 CES4A CFAP44	4.16e-05	195	144	6	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Trm_Th1/Th17\|Liver / Manually curated celltypes from each tissue	EML4 CAMK4 PPP1R15A TRBV5-1 LTB SNX9	4.16e-05	195	144	6	480cc62ee1e5b1aaf6b62be6e5afd7a81236a1b0
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UNC13B CAMK4 FAT3 CSMD3 CSRNP3 FBXW7	4.16e-05	195	144	6	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	DPYD ZBTB20 MED13L GPC5 MAML3 FBXW7	4.28e-05	196	144	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	UNC13B CES1 CLIC6 ERRFI1 ALOX15 AHNAK2	4.28e-05	196	144	6	b246e482f012dd9782b49c2a953acedfa3c1139d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	UNC13B CES1 CLIC6 ERRFI1 ALOX15 AHNAK2	4.28e-05	196	144	6	808c0a7d1889a8f3508ed9790c6dc7ec16bbc840
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	INPP5D DOCK9 N4BP3 SLC2A1 PCDH17 GIMAP6	4.41e-05	197	144	6	a7922f65a8af4a773e4ce80114e4d895a594fa2f
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	INPP5D DOCK9 N4BP3 SLC2A1 PCDH17 GIMAP6	4.41e-05	197	144	6	21a1080e1db3a64f3eccc7aed2b3189332d31038
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	UNC13B SLC2A1 CABLES1 ERRFI1 ENO1 UTRN	4.53e-05	198	144	6	84697f316d9195ebe838cf57f4dbdd9feea43bec
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B DPYD ZBTB20 MED13L GPC5 MAML3	4.53e-05	198	144	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	UNC13B SLC2A1 CABLES1 ERRFI1 ENO1 UTRN	4.53e-05	198	144	6	eda85a592527992b51a00f288cff0c3239c47e6f
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	EPSTI1 CAMK4 DOCK9 WNK1 DNAJB13 LTB	4.53e-05	198	144	6	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	UNC13B CLIC6 COL18A1 ERRFI1 ENO1 UTRN	4.66e-05	199	144	6	debdd7dba774d9ccff7effc3f4c132393d203dfa
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DPYD EPSTI1 DOCK11 TNFRSF14 PPP1R15A UTRN	4.66e-05	199	144	6	155b03b859157013e9142e9248551369127d9204
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	OXR1 DOCK11 INPP5D MED13L TIAM1 MAML3	4.79e-05	200	144	6	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	OXR1 DOCK11 INPP5D MED13L TIAM1 MAML3	4.79e-05	200	144	6	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	ABCA4 DSG2 INPP5D CLIC6 CABLES1 COL18A1	4.79e-05	200	144	6	5fb90118d3abc28d72bc483e68317255090a04c7
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	OXR1 DOCK11 INPP5D MED13L TIAM1 MAML3	4.79e-05	200	144	6	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	10x5'v1-week_17-19-Lymphocytic_T-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CAMK4 DOCK9 TRBV5-1 LTB OLFM2 GIMAP6	4.79e-05	200	144	6	b7ab3f644e6002635771dccaa192a111b4e0ed5b
ToppCell	wk_08-11-Epithelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	UNC13B CLIC6 COL18A1 ERRFI1 ENO1 UTRN	4.79e-05	200	144	6	445fc7995ffc440c6256a6aab0bbf33fb0fea028
ToppCell	10x5'v1-week_17-19-Lymphocytic_T\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CAMK4 DOCK9 TRBV5-1 LTB OLFM2 GIMAP6	4.79e-05	200	144	6	2e01a35caeff5967a8b873c5122500d068dcf54c
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	OXR1 DOCK11 INPP5D MED13L TIAM1 MAML3	4.79e-05	200	144	6	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Macroglial-Glia_progenitor_cell\|1m / Sample Type, Dataset, Time_group, and Cell type.	PPP1R15A SLC2A1 FBXO22 GNL2 ENO1 ENO2	4.79e-05	200	144	6	26940eee4a2f2aafd857964b5607e7dfb65f8d6f
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	OXR1 DOCK11 INPP5D MED13L TIAM1 MAML3	4.79e-05	200	144	6	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	OXR1 DOCK11 INPP5D MED13L TIAM1 MAML3	4.79e-05	200	144	6	33036d21c1c82109284473a515c4f890b33fdd5c
Drug	N-succinylphenylglycine	ENO1 ENO2 ENO3	2.28e-07	3	140	3	CID000448582
Drug	AC1MOUJL	ENO1 ENO2 ENO3	2.28e-07	3	140	3	CID003400924
Drug	C03356	ENO1 ENO2 ENO3	2.28e-07	3	140	3	CID000439988
Drug	3-bromo-2-(bromomethyl)propionic acid	ENO1 ENO2 ENO3	2.28e-07	3	140	3	CID000318915
Drug	C04309	ENO1 ENO2 ENO3	2.28e-07	3	140	3	CID000440293
Drug	2,3-diketo-1-phosphohexane	ENO1 ENO2 ENO3	2.28e-07	3	140	3	CID000192519
Drug	dimethyl chlorophosphate	ENO1 ENO2 ENO3	9.06e-07	4	140	3	CID000101863
Drug	[2-(oxidoamino)-2-oxoethyl]phosphonic acid	ENO1 ENO2 ENO3	9.06e-07	4	140	3	CID011969443
Drug	3-aminoenolpyruvate-2-phosphate	ENO1 ENO2 ENO3	9.06e-07	4	140	3	CID003037152
Drug	2-ptz	ENO1 ENO2 ENO3	9.06e-07	4	140	3	CID000445375
Drug	tricyclohexylammonium	ENO1 ENO2 ENO3	9.06e-07	4	140	3	CID000226271
Drug	Hecameg	TWIST1 ENO1 ENO2 ENO3	1.31e-06	14	140	4	CID002733955
Drug	N-methylacrylamide	ENO1 ENO2 ENO3	2.26e-06	5	140	3	CID000014471
Drug	AC1L1CAI	ENO1 ENO2 ENO3	2.26e-06	5	140	3	CID000000145
Drug	tartronate semialdehyde phosphate	ENO1 ENO2 ENO3	2.26e-06	5	140	3	CID000151938
Drug	2-phospho-3-butenoic acid	ENO1 ENO2 ENO3	2.26e-06	5	140	3	CID000191423
Drug	1-Pdmsp	ENO1 ENO2 ENO3	2.26e-06	5	140	3	CID000000561
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; PC3; HT_HG-U133A	DNAJB12 MAN2A2 CAMK4 RAD54L2 WNK1 HOXC5 TIAM1 TIMELESS CPLANE1	3.89e-06	198	140	9	6300_UP
Drug	N,N-Dichlorourethane	GMPS ENO1 ENO2 ENO3	3.92e-06	18	140	4	CID000026195
Drug	dimidium	ENO1 ENO2 ENO3	4.49e-06	6	140	3	CID000068207
Drug	Z(2-Cl)-OSu	ENO1 ENO2 ENO3	4.49e-06	6	140	3	CID000580665
Drug	4-(N,N-dimethylamino)cinnamoyl-CoA	ENO1 ENO2 ENO3	4.49e-06	6	140	3	CID000445461
Drug	N-tert-butylacrylamide	ENO1 ENO2 ENO3	7.82e-06	7	140	3	CID000007877
Drug	glycidol phosphate	ENO1 ENO2 ENO3	7.82e-06	7	140	3	CID000152659
Drug	lavendustin C6	ENO1 ENO2 ENO3	7.82e-06	7	140	3	CID000126839
Drug	CPEP	ENO1 ENO2 ENO3	7.82e-06	7	140	3	CID000360637
Drug	macrophomate	ENO1 ENO2 ENO3	1.25e-05	8	140	3	CID010889109
Drug	6-[4-[(4-ethyl-2,3-dihydropyrazin-1-yl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	ABCA4 ENO1 ENO2 ENO3	1.84e-05	26	140	4	CID016040258
Drug	AC1L19IJ	ENO1 ENO2 ENO3	1.86e-05	9	140	3	CID000000562
Drug	AC1L1A4W	ENO1 ENO2 ENO3	1.86e-05	9	140	3	CID000000837
Drug	pyrene-4,5-dione	ENO1 ENO2 ENO3	2.65e-05	10	140	3	CID000160814
Drug	L-fuconic acid	ENO1 ENO2 ENO3	2.65e-05	10	140	3	CID000345732
Drug	phosphoenolthiopyruvate	ENO1 ENO2 ENO3	2.65e-05	10	140	3	CID000194910
Drug	xylonate	ENO1 ENO2 ENO3	2.65e-05	10	140	3	CID000010264
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	DNAJB12 PAPPA2 MAN2A2 DRP2 MAML1 SLC2A1 TIMELESS TBX1	2.75e-05	194	140	8	4092_UP
Drug	tetrahydroaldosterone-3-glucuronide	EXTL3 ENO1 ENO2 ENO3	2.89e-05	29	140	4	CID000167918
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; MCF7; HT_HG-U133A	PAPPA2 DOCK9 MAML1 WNK1 USP19 TAF6L ZKSCAN1 TIMELESS	2.96e-05	196	140	8	4714_UP
Drug	Conessine [546-06-5]; Up 200; 11.2uM; MCF7; HT_HG-U133A	RAD54L2 PPP1R15A N4BP3 SLC2A1 SLC25A44 ZNF76 TIMELESS BAHCC1	3.07e-05	197	140	8	2792_UP
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A	DNAJB12 EXTL3 RAD54L2 COL18A1 TIAM1 IGHMBP2 ZNF76 BAHCC1	3.30e-05	199	140	8	5804_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A	UNC13B DNAJB12 ZBTB20 INPP5D TAF6L ATXN2 SLC25A44 ZNF76	3.42e-05	200	140	8	2175_DN
Drug	Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PPP1R15A N4BP3 TAF6L HOXD11 COA1 ZNF76 ENO3 BAHCC1	3.42e-05	200	140	8	2894_UP
Drug	LG61	ENO1 ENO2 ENO3	4.81e-05	12	140	3	CID000520177
Drug	AC1L18ZV	ENO1 ENO2 ENO3	4.81e-05	12	140	3	CID000000329
Drug	B-43	ENO1 ENO2 ENO3	7.88e-05	14	140	3	CID006603792
Drug	pipemidic acid	ENO1 ENO2 ENO3	9.81e-05	15	140	3	CID000004831
Drug	1 IN	ENO1 ENO2 ENO3	9.81e-05	15	140	3	CID000449311
Drug	Freon 22	ENO1 ENO2 ENO3	1.20e-04	16	140	3	CID000006372
Drug	tetraethylenepentamine	SLC2A1 TWIST1 SOD1	1.20e-04	16	140	3	ctd:C034269
Drug	2-PE	ENO1 ENO2 ENO3	1.45e-04	17	140	3	CID000004867
Drug	Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A	ZBTB20 PPP1R15A TAF6L TESK2 IGHMBP2 ZBTB40 ZNF76	1.51e-04	185	140	7	7402_UP
Drug	Tamoxifen citrate [54965-24-1]; Up 200; 7uM; MCF7; HT_HG-U133A	COL4A1 DNAJB12 PPP1R15A IGHMBP2 TIMELESS CFAP44 AHNAK2	1.61e-04	187	140	7	6768_UP
Drug	oxolinic acid	OXR1 ENO1 ENO2 ENO3	1.68e-04	45	140	4	CID000004628
Drug	o-succinylbenzoic acid	ENO1 ENO2 ENO3	1.74e-04	18	140	3	CID000000955
Drug	AC1L1A7Z	ENO1 ENO2 ENO3	1.74e-04	18	140	3	CID000000874
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	PAPPA2 CAD CAMK4 TAF6L ZNF76 ENO1 FBXW7	1.84e-04	191	140	7	5964_DN
Drug	Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MAN2A2 EML4 WNK1 HOXC5 UTRN AHNAK2 FBXW7	1.90e-04	192	140	7	3318_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	EXTL3 RAD54L2 PPP1R15A USP19 ALOX15 AHNAK2 BAHCC1	1.96e-04	193	140	7	3614_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A	DNAJB12 EML4 PPP1R15A TAF6L HOXC5 TIMELESS BAHCC1	2.02e-04	194	140	7	3932_DN
Drug	Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A	DNAJB12 DRP2 N4BP3 TAF6L ZNF76 CFAP44 ENO3	2.02e-04	194	140	7	3302_UP
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A	WNK1 SLC2A1 USP19 COA1 CDK5RAP2 UNKL ENO2	2.02e-04	194	140	7	3604_DN
Drug	purpurin-18	ENO1 ENO2 ENO3	2.05e-04	19	140	3	CID005489047
Drug	AC1L2YVP	ENO1 ENO2 ENO3	2.05e-04	19	140	3	CID000080135
Drug	histidinol phosphate	ENO1 ENO2 ENO3	2.05e-04	19	140	3	CID000000845
Drug	Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; PC3; HT_HG-U133A	PAPPA2 SLC2A1 TAF6L ZKSCAN1 HOXD11 TRPV4 DMBT1	2.09e-04	195	140	7	5885_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	MAML1 EXTL3 BCL9 WNK1 TAF6L ATXN2 ZBTB40	2.09e-04	195	140	7	1665_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	CAMK4 EXTL3 WNK1 TAF6L IGHMBP2 ZBTB40 ZNF76	2.09e-04	195	140	7	2290_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A	DNAJB12 MAML1 BCL9 ZKSCAN1 TIAM1 IGHMBP2 ZBTB40	2.09e-04	195	140	7	2761_DN
Drug	Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A	DNAJB12 RAD54L2 BCL9 WNK1 ZKSCAN1 ZNF76 CAPRIN1	2.15e-04	196	140	7	5301_UP
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	DNAJB12 PAPPA2 CAMK4 DOCK9 KHSRP TIAM1 TIMELESS	2.15e-04	196	140	7	3739_DN
Drug	Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A	MAML1 RAD54L2 N4BP3 HOXC5 IGHMBP2 UTRN CAPRIN1	2.15e-04	196	140	7	3353_DN
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	DNAJB12 CAMK4 PPP1R15A SLC2A1 SLC25A44 ALOX15 BAHCC1	2.15e-04	196	140	7	2818_UP
Drug	Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A	DNAJB12 HOXC5 COA1 ZNF76 TIMELESS CAPRIN1 TGS1	2.15e-04	196	140	7	4166_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	RAD54L2 WNK1 USP19 TIMELESS UTRN ALOX15 BAHCC1	2.22e-04	197	140	7	3934_DN
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	WNK1 CPSF1 ZNF76 TRPV4 UTRN AHNAK2 TGS1	2.22e-04	197	140	7	4818_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	COL4A1 DOCK9 EXTL3 TIMELESS UTRN MAML3 ALOX15	2.29e-04	198	140	7	6001_UP
Drug	WY-14643; Up 200; 100uM; MCF7; HG-U133A	DRP2 CAMK4 MED13L PI3 IGHMBP2 CDK5RAP2 MAML3	2.29e-04	198	140	7	487_UP
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	CDK12 PPP1R15A COL18A1 ITPKC RBM12 ALDH5A1 FBXW7	2.29e-04	198	140	7	7180_DN
Drug	Gabapentin [60142-96-3]; Up 200; 23.4uM; PC3; HT_HG-U133A	ZBTB20 WNK1 PCDH17 USP19 PRDM9 DMBT1 ENO3	2.29e-04	198	140	7	5875_UP
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A	COL4A1 DOCK9 TNFRSF14 WNK1 SLC2A1 HOXC5 SLC15A1	2.29e-04	198	140	7	3642_DN
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A	DOCK9 EXTL3 TAF6L COL18A1 IGHMBP2 ZBTB40 FBXW7	2.29e-04	198	140	7	7390_UP
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A	DNAJB12 DOCK9 BCL9 N4BP3 USP19 TIAM1 AHNAK2	2.29e-04	198	140	7	1519_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; PC3; HT_HG-U133A	PAPPA2 ZBTB20 CAMK4 WNK1 PCDH17 HOXC5 DMBT1	2.29e-04	198	140	7	4187_UP
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A	DPYD KHNYN TOPBP1 CHD9 SLC25A44 CDK5RAP2 TIMELESS	2.29e-04	198	140	7	1579_DN
Drug	Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HT_HG-U133A	DNAJB12 CAMK4 SLC2A1 PCDH17 DMBT1 ENO3 TBX1	2.29e-04	198	140	7	4246_UP
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	DNAJB12 PAPPA2 CAMK4 INPP5D MAML1 WNK1 DMBT1	2.29e-04	198	140	7	4343_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PPP1R15A COL18A1 IGHMBP2 ENO2 ALOX15 BAHCC1 FBXW7	2.29e-04	198	140	7	7035_UP
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	DNAJB12 VPS54 BCL9 COA1 ZBTB40 ENO2 TGS1	2.36e-04	199	140	7	2802_DN
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; PC3; HT_HG-U133A	DNAJB12 PAPPA2 DOCK9 WNK1 SLC2A1 CSRNP3 TBX1	2.36e-04	199	140	7	3987_UP
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	ZBTB20 CAMK4 PCDH17 KHSRP TAF6L ZNF76 ENO3	2.36e-04	199	140	7	6130_UP
Drug	Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A	PAPPA2 CCDC30 PPP1R15A WNK1 SLC2A1 KHSRP CPLANE1	2.36e-04	199	140	7	4159_UP
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A	CAMK4 EXTL3 N4BP3 WNK1 IGHMBP2 ZNF76 FBXW7	2.36e-04	199	140	7	2287_DN
Drug	enoxacin	ENO1 ENO2 ENO3	2.40e-04	20	140	3	CID000003229
Drug	Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; HL60; HT_HG-U133A	DNAJB12 EML4 CAMK4 TWIST1 GIMAP6 BAHCC1 TGS1	2.44e-04	200	140	7	1263_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A	DNAJB12 INPP5D DOCK9 MAML1 RAD54L2 PCDH17 SLC15A1	2.44e-04	200	140	7	6016_UP
Drug	Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A	DNAJB12 KHSRP ZNF76 TRPV4 TIMELESS ENO3 MAML3	2.44e-04	200	140	7	5730_UP
Drug	Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A	PPP1R15A WNK1 USP19 TESK2 COA1 ZBTB40 CPLANE1	2.44e-04	200	140	7	6283_UP
Drug	indomethacin, USP; Up 200; 100uM; MCF7; HG-U133A	MED13L KHSRP COL18A1 TIAM1 ATXN2 KIF5B BAHCC1	2.44e-04	200	140	7	453_UP
Disease	smoking cessation	DNAJB12 DPYD ZBTB20 CDK12 CSMD3 BIRC6 USP19 ATXN2 BSN MAML3	3.48e-06	325	139	10	EFO_0004319
Disease	Colorectal Carcinoma	UNC13B DPYD CAD ABCA4 FRMPD2 WNK1 CSMD3 CABLES1 TIAM1 CSRNP3 OLFM2 TBX1 FBXW7	2.93e-05	702	139	13	C0009402
Disease	peripheral arterial disease	COL4A1 CSMD3 TWIST1 ATXN2	1.24e-04	54	139	4	EFO_0004265
Disease	amyotrophic lateral sclerosis type 1 (implicated_via_orthology)	VPS54 SOD1	1.31e-04	4	139	2	DOID:0060193 (implicated_via_orthology)
Disease	myocardial infarction	COL4A1 PAPPA2 DOCK9 TWIST1 SLC15A1 ATXN2 DMBT1 DNMBP	2.65e-04	350	139	8	EFO_0000612
Disease	ovarian neoplasm	CDK12 BCL9 SLC2A1 HOXD11 SOD1	4.43e-04	134	139	5	C0919267
Disease	Malignant neoplasm of ovary	CDK12 BCL9 SLC2A1 HOXD11 SOD1	4.90e-04	137	139	5	C1140680
Disease	Profound Mental Retardation	MED13L SLC2A1 COL18A1 ZBTB40 ALDH5A1	5.23e-04	139	139	5	C0020796
Disease	Mental Retardation, Psychosocial	MED13L SLC2A1 COL18A1 ZBTB40 ALDH5A1	5.23e-04	139	139	5	C0025363
Disease	Mental deficiency	MED13L SLC2A1 COL18A1 ZBTB40 ALDH5A1	5.23e-04	139	139	5	C0917816
Disease	coronary artery disease	COL4A1 DPYD ZBTB20 CCDC30 CDK12 INPP5D DOCK9 TWIST1 ZKSCAN1 SLC15A1 ATXN2 C1R BSN NLRP4 ALDH5A1	5.25e-04	1194	139	15	EFO_0001645
Disease	Borderline personality disorder	DPYD SNX9 MAML3	6.00e-04	35	139	3	HP_0012076
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	DRP2 EML4 UTRN	6.52e-04	36	139	3	DOID:11723 (implicated_via_orthology)
Disease	hepatocyte growth factor-like protein measurement	RAD54L2 USP19 BSN	7.65e-04	38	139	3	EFO_0008154
Disease	infection	INPP5D ZNF541	7.76e-04	9	139	2	EFO_0000544
Disease	adseverin measurement	C1R DNMBP	9.67e-04	10	139	2	EFO_0801358
Disease	Charcot-Marie-Tooth disease	DRP2 IGHMBP2 TRPV4	1.03e-03	42	139	3	cv:C0007959
Disease	Leukoencephalopathy	COL4A1 DPYD	1.18e-03	11	139	2	C0270612
Disease	fibrinogen measurement, tissue plasminogen activator measurement	CHD9 ATXN2 GIMAP6	1.26e-03	45	139	3	EFO_0004623, EFO_0004791
Disease	forced expiratory volume	CDK12 EML4 DOCK9 TRIM71 BCL9 CABLES1 TWIST1 CELF1 IGHMBP2 ZBTB40 GPC5	1.32e-03	789	139	11	EFO_0004314
Disease	diastolic blood pressure, systolic blood pressure	UNC13B COL4A1 CCDC30 MAML1 BCL9 ATXN2 GNL2 OLFM2 ALOX15 FBXW7	1.32e-03	670	139	10	EFO_0006335, EFO_0006336
Disease	motor neuron disease (implicated_via_orthology)	VPS54 KIF5B	1.41e-03	12	139	2	DOID:231 (implicated_via_orthology)
Disease	Rheumatoid Arthritis	PLB1 TNFRSF14 MMEL1 HOXD11 ENO1	1.43e-03	174	139	5	C0003873
Disease	chronic obstructive pulmonary disease	DPYD EML4 VPS54 BCL9 TWIST1 ZKSCAN1 TESK2 DMBT1 MAML3 TBX1	1.60e-03	688	139	10	EFO_0000341
Disease	ocular hypertension, response to triamcinolone acetonide	CHD9 TMEM132C TIMELESS	1.61e-03	49	139	3	EFO_0006954, EFO_1001069
Disease	Hereditary Motor and Sensory-Neuropathy Type II	WNK1 TRPV4	1.66e-03	13	139	2	C0270914
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	COL4A1 DPYD	1.93e-03	14	139	2	C1858991
Disease	nervous system disorder	DPYD SLC2A1 SOD1	2.02e-03	53	139	3	C0027765
Disease	Mouth Neoplasms	TIAM1 HOXD11 ENO1	2.13e-03	54	139	3	C0026640
Disease	Malignant neoplasm of mouth	TIAM1 HOXD11 ENO1	2.13e-03	54	139	3	C0153381
Disease	severe aplastic anemia	DPYD EPSTI1	2.22e-03	15	139	2	EFO_0006927
Disease	Ischemic stroke, tissue plasminogen activator measurement	TWIST1 ATXN2	2.22e-03	15	139	2	EFO_0004791, HP_0002140
Disease	Ischemic stroke, fibrinogen measurement	CHD9 TWIST1 ATXN2	2.24e-03	55	139	3	EFO_0004623, HP_0002140
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	TWIST1 ATXN2	2.53e-03	16	139	2	EFO_0004792, HP_0002140
Disease	asthma, Eczema, allergic rhinitis	INPP5D TNFRSF14 ATXN2 ALOX15	2.62e-03	121	139	4	EFO_0005854, HP_0000964, MONDO_0004979
Disease	Inborn Errors of Metabolism	CES1 SLC2A1	2.86e-03	17	139	2	C0025521
Disease	Charcot-Marie-Tooth disease type 2	IGHMBP2 TRPV4	2.86e-03	17	139	2	cv:C0270914
Disease	factor XI measurement, Ischemic stroke	TWIST1 ATXN2	2.86e-03	17	139	2	EFO_0004694, HP_0002140
Disease	platelet component distribution width	COL4A1 DOCK9 WNK1 CABLES1 COL18A1 ATXN2 TESK2 ZBTB10 SNX9 TGS1	3.14e-03	755	139	10	EFO_0007984
Disease	C-X-C motif chemokine 16 measurement	ATXN2 ALOX15	3.21e-03	18	139	2	EFO_0010911
Disease	drug-Induced dyskinesia, response to levodopa	EXTL3 TMEM132C	3.21e-03	18	139	2	EFO_0010747, EFO_1000904
Disease	factor VIII measurement, Ischemic stroke	TWIST1 ATXN2	3.57e-03	19	139	2	EFO_0004630, HP_0002140
Disease	reticulocyte measurement	ZBTB20 OXR1 INPP5D PPP1R15A BIRC6 SLC2A1 PIKFYVE CELF1 ATXN2 TESK2 ZBTB40 BSN	4.22e-03	1053	139	12	EFO_0010700
Disease	Neoplastic Cell Transformation	SLC2A1 ERRFI1 ENO2 SOD1	4.30e-03	139	139	4	C0007621
Disease	bone density, lean body mass	CSRNP3 ZBTB40	4.36e-03	21	139	2	EFO_0003923, EFO_0004995
Disease	Neutropenia	DPYD SMARCD2	4.36e-03	21	139	2	C0027947

Protein segments in the cluster

Peptide	Gene	Start	Entry
VQDNIASFGGNPGSV	CES1	201	P23141
GLSSFQQKEATPGGR	BAHCC1	1591	Q9P281
GTGSVQFPGDQDLRF	CDK12	1391	Q9NYV4
TERGAFQTGQGPLDA	BIRC6	2821	Q9NR09
NPGTTANGKVFRIDG	CSMD3	3116	Q7Z407
DSGPLFAGGAQQKRE	ABCA4	1281	P78363
RGRGNFGGQSEQENT	AFG3L2	416	Q9Y4W6
AGSQKEGPEGANLFI	CELF1	391	Q92879
EEGPINIGGLQQFAT	DPYD	146	Q12882
GYSVPGRNGQSQDLV	DNMBP	1476	Q6XZF7
GVGFNPFQERGNNIV	RAD54L2	686	Q9Y4B4
QQVEGASPGRGAQGE	CLIC6	106	Q96NY7
QGDSGGVFAVRDPNT	C1R	651	P00736
QQNFKRGSGQSGPRG	CAPRIN1	671	Q14444
QGNAFQGPREADVVA	CFAP44	1791	Q96MT7
NVGDEGGFAPNILEN	ENO2	206	P09104
LDQSGGGSKPRFENQ	ARMCX4	1381	Q5H9R4
GGSKPRFENQTTEEG	ARMCX4	1386	Q5H9R4
NAGLGNGLLPNVSEE	CDK5RAP2	36	Q96SN8
GVPGQAQVQEKGDFA	COL4A1	241	P02462
PNGKATGEGFVEFRN	RBM12	466	Q9NTZ6
QIIDDEPQAQTSGGG	RAB21	206	Q9UL25
SGLAGQTLFQNPEEG	OLFM2	16	O95897
LGSVLAQDPDLGQNG	PCDH17	491	O14917
EAARKQPGTGGFQIQ	ITPKC	256	Q96DU7
QPGTGGFQIQQDTDG	ITPKC	261	Q96DU7
GIAVGNNDVKQPEGT	KIF5B	566	P33176
RGGGAFVQNSQPVAV	KIF5B	941	P33176
PGGKQFIENGSEFAQ	LACRT	111	Q9GZZ8
SFLPVDQGGSLVGRN	DSG2	671	Q14126
GSNRPQEIEIGESGF	FBXO22	161	Q8NEZ5
AFEQEQLGSPQVRAG	MAML1	306	Q92585
GEIKEEQAQTGQPAG	HOXC5	116	Q00444
KASTNPDRVQGAGGQ	GNL2	16	Q13823
DGNEVAKAQQATPGG	HINT2	36	Q9BX68
SEGTGNGQFLRPQGV	TRIM71	786	Q2Q1W2
QGRQYVDNPTGGKVD	MED13L	1281	Q71F56
EGARSPLNGDQQNGA	MAML3	166	Q96JK9
GFRQGGASQSDKTPE	SLC2A1	466	P11166
RVVGNGIKAQSGNPE	GPC5	431	P78333
REGQGSSAVGFEVPQ	CAMK4	451	Q16566
LQAGQDGPGSQVDTL	FLYWCH1	351	Q4VC44
NPNSGSDQRVVNGGV	ATXN2	536	Q99700
QYGPAAGQGTAVRQL	BSN	2166	Q9UPA5
RNPGEDVERFKQQGG	DDX55	121	Q8NHQ9
KGPSQEGFVSALNGD	CSRNP3	536	Q8WYN3
NAFLDRLQGKSQPGG	EPSTI1	286	Q96J88
ATQGPTVFAGNIGDN	CPSF1	601	Q10570
DVDTAAGGFQQRQGL	FBXO3	176	Q9UK99
AQPQGQAVARGAGEA	PNMA6F	106	A0A0J9YX94
AQAGGADPDKFQGVI	COL18A1	621	P39060
VQENIAAFGGDPGNV	CES4A	201	Q5XG92
GTGRTVGEDPQGLFQ	ALOX15	111	P16050
GQDTVKGRVPFNGQD	PI3	31	P19957
KSLGERGNPQGQVDS	NLRP4	536	Q96MN2
IQAQGPGRKGEENST	PCDHB10	776	Q9UN67
FNTLGENIADNGGVR	MMEL1	671	Q495T6
SNRIGQGAAFSPEGQ	MEIS3P2	311	A8K0S8
ENNGPGASLGRVFAQ	PCDHAC1	456	Q9H158
VGSLFQEAEPQSRGG	MYO15B	186	Q96JP2
EESRTGQKVNPGNTG	PRDM9	496	Q9NQV7
QIADNFQGISGPKED	OXR1	426	Q8N573
EGGQNNPAIIAGVFD	PAPPA2	296	Q9BXP8
NKERAEGGQGEQQPL	PIKFYVE	56	Q9Y2I7
NVGDEGGFAPNILEN	ENO1	206	P06733
QKRPFDGEDGALGQQ	CHD9	2366	Q3L8U1
EQGFRAIIISGGPNS	GMPS	66	P49915
ATGFPDQGNTGENTR	DOCK11	1246	Q5JSL3
PFTQTGKRQGGVEEQ	DOCK9	1901	Q9BZ29
PGQGGSTSAFEQLQR	CABLES1	266	Q8TDN4
VATPGGTEERNGQNK	CPLANE1	1836	Q9H799
IISQSKGVGGNNPDE	FRMPD2	856	Q68DX3
SGKEFQAALGGNVPR	EXTL3	646	O43909
DEKEFTGAQSGGPQQ	BCL9	376	O00512
NGFIGQELNSGRESP	COL6A5	2206	A8TX70
RDNQGDGGLGVFVQL	DNAJB12	236	Q9NXW2
PNVAEAGEQFGQLGR	F8A1;	41	P23610
STVNGERPENNKGGI	FAT3	2741	Q8TDW7
PTTFGDLRAANGQGQ	FBXW7	206	Q969H0
SAVGRNGILPQGFDQ	HOXD11	166	P31277
GSFPREGQKEEGSQQ	CCDC30	161	Q5VVM6
AGQEDNQGNRAPGTV	DNAAF8	276	Q8IYS4
ISPQDCQFALGGRGQ	MAN2A2	111	P49641
GTRITFEKEGDQGPN	DNAJB13	191	P59910
PSRGFAEHGKQQQGR	KHNYN	606	O15037
NVGDEGGFAPNILEN	ENO3	206	P13929
LRGTFNDGFQIEVQG	EML4	576	Q9HC35
TVNVAFGGKPIEQGD	SDR42E2	146	A6NKP2
GELQPQGTVGKDEQA	ERICH5	201	Q6P6B1
NAQFGQGSGPIVLDD	DMBT1	286	Q9UGM3
NARFGQGSGPIVLDD	DMBT1	546	Q9UGM3
NAQFGQGSGPIVLDD	DMBT1	1561	Q9UGM3
PEKGENGIRFVNTFN	SLC15A1	481	P46059
IPEGLQGAEDTQNGT	DUXA	176	A6NLW8
DGQQIPVFKLSGENG	COA1	126	Q9GZY4
VPRQLGEVAAFGGSN	DRP2	541	Q13474
VPRGQGSQFADGQRA	PPP1R15A	126	O75807
SNKNRPEDYQGGRTG	PDIA6	106	Q15084
VNNSTPDFGFGGQKR	KHSRP	96	Q92945
QQGPGTGTRDVFQKS	TAF6L	536	Q9Y6J9
IPRQLGEVAAFGGSN	UTRN	3001	P46939
GTEGPAKQENFILGS	ROGDI	51	Q9GZN7
GAQPEGAGAQRNTNT	SNX9	126	Q9Y5X1
GNGFEEGTTQGPLIN	ALDH5A1	371	P51649
RVKFGQNDADSSPGG	TMEM132C	796	Q8N3T6
NQPVDTAGRGQLYGG	SLC25A34	236	Q6PIV7
RQVSQGQGSEDVPGE	GIMAP6	251	Q6P9H5
GPGTVDSQGQIEFLR	INPP5D	721	Q92835
VRGNPEGQGVVAFGQ	SLC25A44	151	Q96H78
PSAQQNGLAAGGVDE	PLB1	181	Q6P1J6
GDGPVQGIINFEQKE	SOD1	11	P00441
FREAEETNGGAQIQP	ERRFI1	411	Q9UJM3
QETDGFQVKRPGDLN	SMARCD2	281	Q92925
ADFGLQEDAPGRQGS	AHNAK2	66	Q8IVF2
GQQDGAGNPERLDFS	TRIML2	276	Q8N7C3
FRDQNPEQLAGVGQG	TIMELESS	226	Q9UNS1
TVSGILQGPFDLGNQ	UNC45B	401	Q8IWX7
SAPGQGGILAQREFD	SSR2	126	P43308
EAEINYNNPLGTGGR	USP19	531	O94966
RQQATLGAADEQGGP	ZNF497	56	Q6ZNH5
GGRTNKGPNVFSVSD	ZC3H6	231	P61129
ATQREGNSGGKIQPE	ZNF223	71	Q9UK11
KQGRPSINQVFGEGT	TIAM1	706	Q13009
GSQRQEGGQEAAAPA	IGHMBP2	676	P38935
QERQQAGAQGPGSAD	TNKS1BP1	1061	Q9C0C2
PQGFLIDTSQGVRGQ	TMED6	91	Q8WW62
GQAGFGEQEKPLEVT	UNC13B	306	O14795
NGAEQGRQLSIEGPF	STH	86	Q8IWL8
GRQLSIEGPFQGQNC	STH	91	Q8IWL8
KEERGRGNFPDQFSG	TRBV5-7	71	A0A0A0MS05
ETQRNKGNFPGRFSG	TRBV5-1	71	A0A578
NERPDGVLLTFGGQT	CAD	466	P27708
AEGGPRGSEQDSKQN	UNKL	346	Q9H9P5
NVGDVFPGIQDSGQD	ZBTB20	196	Q9HC78
PGQRVQKGGTESQDT	TNFRSF14	146	Q92956
GQEGVDQGQDTEFPR	ZBTB10	816	Q96DT7
PFNTQGLVAGRTAGD	TBX1	381	O43435
GSAFPQGGENRNENE	ZKSCAN1	261	P17029
SLAGPGGQVEIEQNF	TGS1	816	Q96RS0
GGGSAKEPQEERSQQ	WNK1	186	Q9H4A3
QERGQEGAQDCKFPG	RPTN	101	Q6XPR3
SILQEENGFGSRPQG	TESK2	516	Q96S53
INSGGGVRFNQLNED	TOPBP1	381	Q92547
GGGSPQSYEELQTQR	TWIST1	96	Q15672
AQARGRFFQPKDEGG	TRPV4	266	Q9HBA0
IPRNGKGQQVGDRAF	ZNF76	151	P36508
QGETGSLPGQQEKEA	ZBTB40	711	Q9NUA8
NDGGPQNGLVTADVA	VPS54	936	Q9P1Q0
DIFPSTGQRQTQLGG	ZNF541	691	Q9H0D2
TETADPGAQAQQGLG	LTB	56	Q06643
RGLGDEDGSNPFTQV	N4BP3	271	O15049